201 related articles for article (PubMed ID: 37338608)
1. The additive effect of vitamin K supplementation and bisphosphonate on fracture risk in post-menopausal osteoporosis: a randomised placebo controlled trial.
Moore AE; Dulnoan D; Voong K; Ayis S; Mangelis A; Gorska R; Harrington DJ; Tang JCY; Fraser WD; Hampson G
Arch Osteoporos; 2023 Jun; 18(1):83. PubMed ID: 37338608
[TBL] [Abstract][Full Text] [Related]
2. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.
Cheung AM; Tile L; Lee Y; Tomlinson G; Hawker G; Scher J; Hu H; Vieth R; Thompson L; Jamal S; Josse R
PLoS Med; 2008 Oct; 5(10):e196. PubMed ID: 18922041
[TBL] [Abstract][Full Text] [Related]
3. Serum vitamin K
Moore AE; Kim E; Dulnoan D; Dolan AL; Voong K; Ahmad I; Gorska R; Harrington DJ; Hampson G
Bone; 2020 Dec; 141():115630. PubMed ID: 32919111
[TBL] [Abstract][Full Text] [Related]
4. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial.
Rønn SH; Harsløf T; Oei L; Pedersen SB; Langdahl BL
Osteoporos Int; 2021 Jan; 32(1):185-191. PubMed ID: 33030563
[TBL] [Abstract][Full Text] [Related]
5. Vitamin K to prevent fractures in older women: systematic review and economic evaluation.
Stevenson M; Lloyd-Jones M; Papaioannou D
Health Technol Assess; 2009 Sep; 13(45):iii-xi, 1-134. PubMed ID: 19818211
[TBL] [Abstract][Full Text] [Related]
6. A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates.
Cosman F; Gilchrist N; McClung M; Foldes J; de Villiers T; Santora A; Leung A; Samanta S; Heyden N; McGinnis JP; Rosenberg E; Denker AE
Osteoporos Int; 2016 Jan; 27(1):377-86. PubMed ID: 26556736
[TBL] [Abstract][Full Text] [Related]
7. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age.
Braam LA; Knapen MH; Geusens P; Brouns F; Hamulyák K; Gerichhausen MJ; Vermeer C
Calcif Tissue Int; 2003 Jul; 73(1):21-6. PubMed ID: 14506950
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
9. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis.
Deane A; Constancio L; Fogelman I; Hampson G
BMC Musculoskelet Disord; 2007 Jan; 8():3. PubMed ID: 17214897
[TBL] [Abstract][Full Text] [Related]
10. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E
Osteoporos Int; 2013 Sep; 24(9):2499-507. PubMed ID: 23525894
[TBL] [Abstract][Full Text] [Related]
11. [New spine and non-spine fractures in 871 women/year treated with oral pamidronate plus calcium and vitamin D supplements].
Man Z; Otero AB
Medicina (B Aires); 1997; 57 Suppl 1():32-6. PubMed ID: 9567352
[TBL] [Abstract][Full Text] [Related]
12. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women.
Knapen MH; Schurgers LJ; Vermeer C
Osteoporos Int; 2007 Jul; 18(7):963-72. PubMed ID: 17287908
[TBL] [Abstract][Full Text] [Related]
13. Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial.
Emaus N; Gjesdal CG; Almås B; Christensen M; Grimsgaard AS; Berntsen GK; Salomonsen L; Fønnebø V
Osteoporos Int; 2010 Oct; 21(10):1731-40. PubMed ID: 19937427
[TBL] [Abstract][Full Text] [Related]
14. Calcium plus vitamin D supplementation has limited effects on femoral geometric strength in older postmenopausal women: the Women's Health Initiative.
Jackson RD; Wright NC; Beck TJ; Sherrill D; Cauley JA; Lewis CE; LaCroix AZ; LeBoff MS; Going S; Bassford T; Chen Z
Calcif Tissue Int; 2011 Mar; 88(3):198-208. PubMed ID: 21253715
[TBL] [Abstract][Full Text] [Related]
15. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis.
Bolland MJ; Grey A; Avenell A
Lancet Diabetes Endocrinol; 2018 Nov; 6(11):847-858. PubMed ID: 30293909
[TBL] [Abstract][Full Text] [Related]
16. Treatment for osteoporosis in people with ß-thalassaemia.
Bhardwaj A; Swe KM; Sinha NK; Osunkwo I
Cochrane Database Syst Rev; 2016 Mar; 3():CD010429. PubMed ID: 26964506
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.
Avenell A; Mak JC; O'Connell D
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD000227. PubMed ID: 24729336
[TBL] [Abstract][Full Text] [Related]
18. Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial.
Di Daniele N; Carbonelli MG; Candeloro N; Iacopino L; De Lorenzo A; Andreoli A
Pharmacol Res; 2004 Dec; 50(6):637-41. PubMed ID: 15501704
[TBL] [Abstract][Full Text] [Related]
19. Skeletal response to treatment with teriparatide (TPD) after bisphosphonate in post-menopausal women with osteoporosis and a high prevalence of secondary risk factors in real-life setting of a metabolic bone clinic; effect of age and vitamin D status.
Mok J; Brown C; Moore AEB; Min SS; Hampson G
Endocr Res; 2018 Aug; 43(3):195-202. PubMed ID: 29652557
[TBL] [Abstract][Full Text] [Related]
20. Effects of vitamin K in postmenopausal women: mini review.
Guralp O; Erel CT
Maturitas; 2014 Mar; 77(3):294-9. PubMed ID: 24342502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
